- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01590849
Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
São Paulo
-
Sao Paulo, São Paulo, Brazil, 05403-000
- Marcelo Gil Nisenbaum
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 20 to 40 years old
- no use of hormonal contraceptives for at least 6 months before the study
- need for contraceptive method
- willingness to participate in the study
Exclusion Criteria:
- positive pregnancy test
- category 3 or 4 classification on WHO's Medical Eligibility Criteria for Contraceptive
- smoking
- obesity
- fasting glucose above 100 mg/dL
- abnormalities in lipid profile
- use of other medications
Study Plan
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: No hormonal contraception
|
|
Active Comparator: Hormonal Contraceptive
healthy women, users of COC containing 20 mcg EE and 3 mg DRSP (Yaz®), 24 days of active pills, 4 days of pill-free interval (n=40).
|
After a counseling session concerning the advantages, disadvantages and side effects of contraceptive methods (COC or nonhormonal methods), the volunteers were divided into two study groups according to the method they chose to use as follows:
Subjects were tested once before the introduction of the contraceptive method and again after 6 months of its use.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
combined hormonal oral contraceptive with drospirenone and its influence on the autonomic nervous system
Time Frame: six months after the intervention
|
The participants in this study will be 80 healthy women. After a counseling session concerning the advantages, disadvantages and side effects of contraceptive methods (COC or nonhormonal methods), the volunteers were divided into two study groups according to the method they chose to use as follows:
The acquisition of autonomic parameters will be performed through the device Finometer. |
six months after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
combined hormonal oral contraceptive with drospirenone and its influence on blood pressure
Time Frame: six month after the intervention
|
six month after the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marcelo G Nisenbaum, University of Sao Paulo General Hospital
Publications and helpful links
General Publications
- Carter JR, Klein JC, Schwartz CE. Effects of oral contraceptives on sympathetic nerve activity during orthostatic stress in young, healthy women. Am J Physiol Regul Integr Comp Physiol. 2010 Jan;298(1):R9-R14. doi: 10.1152/ajpregu.00554.2009. Epub 2009 Oct 14.
- Minson CT, Halliwill JR, Young TM, Joyner MJ. Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives. Circulation. 2000 Sep 26;102(13):1473-6. doi: 10.1161/01.cir.102.13.1473.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- nisenbaum1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraceptive Affecting the Autonomic Nervous System
-
ASST Fatebenefratelli SaccoCompletedIntervention Affecting Autonomic Nervous SystemItaly
-
ASST Fatebenefratelli SaccoCompletedIntervention Affecting Autonomic Nervous SystemItaly
-
Federal University of Health Science of Porto AlegreCompletedVertebra; Degeneration | Other Disorders of the Autonomic Nervous SystemBrazil
-
Children's & Women's Health Centre of British ColumbiaCompletedThe Effect of Head Massage Therapy on the Autonomic Nervous SystemCanada
-
University of California, San FranciscoNational Cancer Institute (NCI); Food and Drug Administration (FDA)CompletedAdverse Effect of Other Agents Primarily Affecting the Cardiovascular System, Initial EncounterUnited States
-
The Hong Kong Polytechnic UniversityUnknownAutonomic Nervous System DisorderChina
-
Northwell HealthEnrolling by invitationAutonomic Nervous System Diseases | Autonomic Dysfunction | Autonomic Imbalance | Vagus Nerve Autonomic DisorderUnited States
-
Istanbul Medipol University HospitalCompletedVagus Nerve Autonomic DisorderTurkey
-
Virginia Polytechnic Institute and State UniversityNot yet recruiting
-
University of Mississippi Medical CenterVicor Technologies, Inc.CompletedAutonomic DysfunctionUnited States
Clinical Trials on Contraceptives, Oral, Combined (Yaz®)
-
BayerCompleted
-
University of Southern CaliforniaUnited States Department of DefenseCompleted
-
University of Southern CaliforniaUnknownOral ContraceptiveUnited States
-
Hoffmann-La RocheCompletedHealthy VolunteerUnited Kingdom
-
Boehringer IngelheimTerminated
-
UCB Biopharma SRLTerminatedHealthy Female ParticipantsUnited Kingdom
-
AstraZenecaCompletedScientific Terminology Rheumatoid Arthritis, Healthy Female Volunteers, Pharmacokinetics, Oral Contraceptive, Drug-drug Interaction | Laymen Terminology Level of Oral Contraceptive in Blood, Oral Contraceptive, Rheumatoid Arthritis, Drug -Drug InteractionUnited Kingdom
-
Boehringer IngelheimRecruiting
-
Novo Nordisk A/SCompleted
-
Boehringer IngelheimCompleted